Medication info

Megaacetadolsemisuspension Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
Light yellow round sustained-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202001289 · Approved 2020.02.24

This product's status changed to Approval withdrawn on 2024.07.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 12 hours, and no more than 8 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust treatment appropriately. Elderly: Use the usual adult dose. However, when tramadol is administered orally to elderly patients 75 years of age or older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; use is not recommended.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate acute pain
  • severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Subsequent doses should be given at intervals of at least 12 hours, and no more than 8 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust treatment appropriately. Elderly: Use the usual adult dose. However, when tramadol is administered orally to elderly patients 75 years of age or older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; use is not recommended.

Precautions

This medication may put strain on the liver, so individuals who consume large amounts of alcohol regularly should consult a doctor or pharmacist before taking it. The ingredients in this medication can very rarely cause severe allergic skin reactions; if symptoms such as skin rashes or itching occur, discontinue use immediately and seek medical attention. The ingredients in this medication may pose a risk of seizures, so patients with a history of seizures or those at high risk for seizures should take caution when using this medication. Severe allergic reactions can rarely occur when taking this medication, so if symptoms such as difficulty breathing or hives occur, seek medical care immediately. Patients with acute asthma may find it difficult to breathe while taking this medication; it should only be administered under medical supervision, and alternative pain relievers should be considered if possible. Taking this medication in combination with alcohol or other central nervous system depressants can increase the risk of severe drowsiness, respiratory depression, and coma; co-administration should be avoided if possible. Patients with head injuries or brain disorders should exercise caution when taking this medication as it may increase intracranial pressure. This medication may lead to physical or mental dependence, so long-term use should be managed under a doctor's direction, and sudden discontinuation should be avoided. Patients with impaired liver function must consult a doctor before taking this medication, and should not exceed the recommended dosage due to the risk of liver damage. In patients with certain genetic predispositions, the active ingredient may be metabolized excessively, increasing the risk of respiratory depression; these patients will need dosage adjustments and monitoring. Children under 12 years old and adolescents under 18 years old after certain surgeries should not take this medication; those between 12 and 18 years old with special risk factors should also avoid using it. Taking this medication may cause rare cases of hyponatremia, which is a decrease in sodium concentration in the blood; therefore, older patients or those with risk factors should have regular blood tests. This medication is contraindicated for patients with allergies to certain ingredients, those suffering from central nervous system drug addiction, severe respiratory depression, head trauma, and those taking MAO inhibitors. Pregnant or breastfeeding women should consult healthcare providers before taking this medication, and breastfeeding mothers should either discontinue breastfeeding or observe their condition carefully when using this medication. This medication may cause drowsiness or dizziness, so caution is advised when driving or operating dangerous machinery.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremor, ataxia, convulsions, hypertonia, migraine, worsening of migraine, involuntary muscle contractions, paresthesia, stupor, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stool, tongue swelling, loss of appetite, anxiety, confusion, intoxication, insomnia, neurosensitivity, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urinary dysfunction, oliguria, urinary retention, pruritus, rash, sweating, urticaria, liver function abnormalities, weight loss, tinnitus, abnormal visual field, chills, vasodilation, orthostatic hypotension, bradycardia, exhaustion, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, exercise weakness, respiratory inhibition, cognitive dysfunction, concentration difficulties, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, emotional changes, activity changes, cognitive changes, sensory function changes, prolonged prothrombin time, altered warfarin effect, serotonin syndrome, worsening of asthma, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, motor disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, leukoplakia, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory anomalies, stupor, taste abnormalities, involuntary muscle contractions, migraine, dark urine, anuria, urinary retention, urinary incontinence, upper abdominal pain, peptic ulcer, belching, chest discomfort, facial swelling, fever, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, hematuria, hypertension, palpitations, irregular menstruation, breast cancer, trauma, congestive heart failure, dizziness, stupor, exertional dyspnea, bronchitis, urinary retention, frequency of urination, abnormal kidney function tests, hematochezia, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, paralytic ileus, hiccups, cholecystitis, memory impairment, lack of efficacy, facial flushing, heartburn, unspecified gastrointestinal disorder, acute gastritis, cold, upper respiratory tract infection, general weakness, motion sickness, transient ischemic attack, lethargy, stupor, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, multiple organ failure, intentional overdose, withdrawal symptoms, panic attacks, severe anxiety, sensory anomalies, tinnitus, abnormal central nervous system responses, opioid-induced hyperalgesia, symptoms of adrenal insufficiency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and humidity and must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's efficacy and safety.

Appearance and packaging

Appearance

Light yellow round sustained-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.